Eric P Kaldjian Selected Research

Eric P Kaldjian Research Topics

11	Neoplasms (Cancer) 01/2022 - 09/2002
2	Circulating Neoplastic Cells 01/2022 - 01/2022
2	Breast Neoplasms (Breast Cancer) 03/2019 - 11/2004
1	Triple Negative Breast Neoplasms 08/2010
1	Carcinogenesis 08/2010
1	Chromosome Aberrations (Chromosome Abnormalities) 05/2007
1	Ovarian Neoplasms (Ovarian Cancer) 08/2005
1	Pancreatic Neoplasms (Pancreatic Cancer) 11/2004
1	Colonic Neoplasms (Colon Cancer) 11/2004
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2004
1	Aneurysm (Aneurysms) 11/2004
1	Abdominal Aortic Aneurysm 11/2004

4	Proteins (Proteins, Gene)FDA Link 01/2022 - 07/2004
3	Biomarkers (Surrogate Marker)IBA 01/2022 - 05/2015
2	Messenger RNA (mRNA)IBA 05/2007 - 09/2002
1	Immune Checkpoint InhibitorsIBA 01/2022
1	Interferon Regulatory Factor-1 (Interferon Regulatory Factor 1)IBA 01/2022
1	Epithelial Cell Adhesion MoleculeIBA 03/2019
1	AntibodiesIBA 03/2019
1	Progesterone Receptors (Progesterone Receptor)IBA 08/2010
1	human ERBB2 proteinIBA 08/2010
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 08/2010
1	Poly (ADP-Ribose) Polymerase-1IBA 08/2010
1	Estrogen ReceptorsIBA 08/2010
1	MicroRNAs (MicroRNA)IBA 05/2007
1	DNA (Deoxyribonucleic Acid)IBA 05/2007
1	Canertinib (CI 1033)IBA 08/2005
1	PlatinumIBA 08/2005
1	ErbB Receptors (EGF Receptor)IBA 08/2005
1	2- (2- chloro- 4- iodophenylamino)- N- cyclopropylmethoxy- 3,4- difluorobenzamideIBA 11/2004
1	MitogensIBA 11/2004
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 11/2004
1	MAP Kinase Kinase Kinases (MAP Kinase Kinase Kinase)IBA 11/2004
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 11/2004
1	mirdametinibIBA 11/2004
1	Matrix Metalloproteinases (MMPs)IBA 11/2004
1	Pancreatic Elastase (Elastase)IBA 11/2004
1	Estradiol (Delestrogen)FDA LinkGeneric 11/2004
1	RNA (Ribonucleic Acid)IBA 07/2004
1	Antineoplastic Agents (Antineoplastics)IBA 07/2004
1	Nucleic AcidsIBA 09/2002

5	Therapeutics 01/2022 - 08/2005